197 related articles for article (PubMed ID: 32540133)
1. IL-36 in chronic inflammation and cancer.
Neurath MF
Cytokine Growth Factor Rev; 2020 Oct; 55():70-79. PubMed ID: 32540133
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
4. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
Gabay C; Towne JE
J Leukoc Biol; 2015 Apr; 97(4):645-52. PubMed ID: 25673295
[TBL] [Abstract][Full Text] [Related]
5. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway.
Li Q; Liu S; Li L; Ji X; Wang M; Zhou J
Glia; 2019 Mar; 67(3):438-451. PubMed ID: 30578562
[TBL] [Abstract][Full Text] [Related]
6. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
Walsh PT; Fallon PG
Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
Sachen KL; Arnold Greving CN; Towne JE
Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
[TBL] [Abstract][Full Text] [Related]
8. Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.
Nishikawa H; Taniguchi Y; Matsumoto T; Arima N; Masaki M; Shimamura Y; Inoue K; Horino T; Fujimoto S; Ohko K; Komatsu T; Udaka K; Sano S; Terada Y
Kidney Int; 2018 Mar; 93(3):599-614. PubMed ID: 29241623
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of interleukin-36 cytokines.
Bassoy EY; Towne JE; Gabay C
Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-36: Structure, Signaling and Function.
Zhou L; Todorovic V
Adv Exp Med Biol; 2021; 21():191-210. PubMed ID: 32026417
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.
Nishida A; Hidaka K; Kanda T; Imaeda H; Shioya M; Inatomi O; Bamba S; Kitoh K; Sugimoto M; Andoh A
Inflamm Bowel Dis; 2016 Feb; 22(2):303-14. PubMed ID: 26752465
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin-36 in health and disease states.
Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38779986
[TBL] [Abstract][Full Text] [Related]
14. Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development.
Queen D; Ediriweera C; Liu L
Front Cell Dev Biol; 2019; 7():317. PubMed ID: 31867327
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
17. Biology of IL-36 cytokines and their role in disease.
Gresnigt MS; van de Veerdonk FL
Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
[TBL] [Abstract][Full Text] [Related]
18. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
[TBL] [Abstract][Full Text] [Related]
20. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients.
Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P
Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
